My first medical freedom fight occurred during the second year of my surgical
residency when I took on U.S. Surgical and Ethicon Endosurgery (a subsidiary of
Johnson & Johnson) over the hazards of their titanium surgical clips, used
routinely in all kinds of operations. I observed with horror of what everyone else saw
but shrugged off as something we surgeons, and patients, just had to live with: the
surgical clips made by these companies often just fell off the structures to which
they were meant to remain fixed. The consequences, as I learned one day when a
new admission rolled into the surgical ICU where I was then in charge, could be
catastrophic: bleeding, post-operative complications, death. Against all advice,
including that of the Chairman of the Department of Surgery where I was training, I
hired a mechanical engineer, designed a surgical clip that would not fall off,
designed a device to remove the clip safely in the event it was placed incorrectly,
had the new clip (the Ruddy Clip) patented and approved by the FDA for use in
humans – in less than two years. I presented my Ruddy Clip to the surgical faculty
when I became Chief Resident, and was roundly applauded and congratulated.
My next medical freedom fight took place during the time I spent at McGill
University completing the first International Masters for Health Leadership
program (2006-2008.) I learned that a breast cancer virus had been discovered by
Dr. John Bittner in 1936, and that subsequent researchers (including many at the
National Cancer Institute) had shown to exist in a large portion of women with
breast cancer. And yet, as the first Breast Fellow on the Surgical Oncology Service
at Memorial Sloan-Kettering Cancer Center, I had never heard a doctor mention or
discuss this breast cancer virus. Immediately after I completed the Masters
program at McGill University, I created the world’s first breast cancer foundation
dedicated to discovering the causes of breast cancer and using that knowledge to
prevent the disease. I placed answering the question, Does a virus cause breast
cancer in women, the first priority. I wrote a book on this subject, “The End of
Breast Cancer: A Virus and the Hope for a Vaccine,” which was published by
Skyhorse Publishing (2015.) Today, we are 90% certain that this virus plays a role
in up to 94% of all cases of breast cancer, with or without a BRCA mutation playing
a role.
Medical freedom fighting took an unexpected turn when I discovered in 2019 that
Governor Phil Murphy (R-NJ) was supporting a bill that would require all doctors
like myself who were licensed in the state of NJ to perform abortions regardless of
their conscientious or religious objection. A few months later, the Supreme Court
agreed to hear the Dobbs v Jackson Women’s Health Institute abortion case,
which some hoped might over rule the Roe decision. Immediately, I conceived of three arguments why the Dobbs decision should prevail over the prior Roe decision, and I wrote a book putting forth my arguments, The Viability of Roe. The
book made its way into the hands of the Supreme Court justices and became part
of an amicus brief in the Dobbs case. I was thrilled to see one of my arguments –
concerning the issue of the viability of the fetus – cited in the first draft and final
decision in the Dobbs case, which over ruled the Roe decision and threw the
legality of abortion back to the states for further deliberation.
And then COVID broke out. Based on my experiences at McGill University where I
worked with colleagues who’d managed the first SARS CoV-1 outbreak in Toronto,
and as a result of serving on the Leadership Council of the Harvard School of
Public Health during the ebola outbreak in west Africa more than a decade ago, I
was familiar with viruses, contagious diseases, international healthcare responses
to crises, the nature of the spread of respiratory contagion, and the utter failure of
prior scientists to make a safe and effective vaccine against a SARS coronavirus. I
pushed back against the reckless rollout of the COVID mRNA vaccines, the
vaccine mandates, and the systematic institutional obstruction of the use of
ivermectin for the prevention and treatment of COVID.
My experience treating COVID patients with ivermectin – all with excellent results
and no untoward effects – led me to study ivermectin more thoroughly. I
discovered two decades of laboratory research that strongly suggested ivermectin
held great potential in the treatment of cancer. What in the name of all that is good
and holy is going on, I asked myself. A virus causes breast cancer in women, and
ivermectin is a potentially powerful cancer treatment, and nothing is being done to
push these questions forward toward answers and solutions? Time for the
equivalent of another ‘Ruddy Clip’.
And now for the freedom fight of my life: I have recently launched the country’s
first observational, longitudinal study (the Alpha Study) to evaluate the efficacy of
ivermectin and other FDA-approved repurposed drugs to improve the survival of
patients with Stage III unresectable cancer and patients with Stage IV cancer. Early
anecdotal reports from around the world are very promising, but only a properly
designed and appropriately executed scientific study will answer the many
questions that have been raised about the efficacy of ivermectin in the treatment
of all kinds of cancer.
For more information about the Alpha Study, please contact me at
KathleenTRuddyMD@protonmail.com